368 related articles for article (PubMed ID: 18266750)
21. Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.
Horzinski L; Gonthier C; Rodriguez D; Scherer C; Boespflug-Tanguy O; Fogli A
Ann Hum Genet; 2008 May; 72(Pt 3):410-5. PubMed ID: 18294360
[TBL] [Abstract][Full Text] [Related]
22. Vanishing white matter disease associated with ptosis and myoclonic seizures.
Sharma S; Arya R; Raju KN; Kumar A; Scheper GC; van der Knaap MS; Gulati S
J Child Neurol; 2011 Mar; 26(3):366-8. PubMed ID: 21115745
[TBL] [Abstract][Full Text] [Related]
23. Vanishing white matter disease: a review with focus on its genetics.
Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS
Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905
[TBL] [Abstract][Full Text] [Related]
24. FAME 3: a novel form of progressive myoclonus and epilepsy.
Carr JA; van der Walt PE; Nakayama J; Fu YH; Corfield V; Brink P; Ptacek L
Neurology; 2007 Apr; 68(17):1382-9. PubMed ID: 17452583
[TBL] [Abstract][Full Text] [Related]
25. Leukoencephalopathy with vanishing white matter: a review.
Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
[TBL] [Abstract][Full Text] [Related]
26. Arg113His mutation of vanishing white matter is not present in multiple sclerosis.
Lucas M; Suarez R; Marcos A; Solano F; Venegas A; Garcia-Sanchez MI; Ortiz L; Izquierdo G
Mult Scler; 2007 Apr; 13(3):424-7. PubMed ID: 17439913
[TBL] [Abstract][Full Text] [Related]
27. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
[TBL] [Abstract][Full Text] [Related]
28. Leukoencephalopathy with vanishing white matter due to homozygous EIF2B2 gene mutation. First Polish cases.
Mierzewska H; van der Knaap MS; Scheper GC; Jurkiewicz E; Schmidt-Sidor B; Szymańska K
Folia Neuropathol; 2006; 44(2):144-8. PubMed ID: 16823698
[TBL] [Abstract][Full Text] [Related]
29. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.
Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N
Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207
[TBL] [Abstract][Full Text] [Related]
30. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
[TBL] [Abstract][Full Text] [Related]
31. Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.
Terumitsu-Tsujita M; Kitaura H; Miura I; Kiyama Y; Goto F; Muraki Y; Ominato S; Hara N; Simankova A; Bizen N; Kashiwagi K; Ito T; Toyoshima Y; Kakita A; Manabe T; Wakana S; Takebayashi H; Igarashi H
J Neurochem; 2020 Jul; 154(1):25-40. PubMed ID: 31587290
[TBL] [Abstract][Full Text] [Related]
32. Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults.
van der Knaap MS; Leegwater PA; van Berkel CG; Brenner C; Storey E; Di Rocco M; Salvi F; Pronk JC
Neurology; 2004 May; 62(9):1598-600. PubMed ID: 15136689
[TBL] [Abstract][Full Text] [Related]
33. A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
Fogli A; Dionisi-Vici C; Deodato F; Bartuli A; Boespflug-Tanguy O; Bertini E
Neurology; 2002 Dec; 59(12):1966-8. PubMed ID: 12499492
[TBL] [Abstract][Full Text] [Related]
34. A rare mutation in EIF2B4 gene in an epileptic child with vanishing white matter disease: a case report.
Gungor O; Ozkaya AK; Hirfanoglu T; Dilber C; Aydin K
Genet Couns; 2015; 26(1):41-6. PubMed ID: 26043506
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
[TBL] [Abstract][Full Text] [Related]
36. Vanishing white matter disease: the first reported chinese patient.
Wong SS; Luk DC; Wong VC; Scheper GC; van der Knaap MS
J Child Neurol; 2008 Jun; 23(6):710-4. PubMed ID: 18539998
[TBL] [Abstract][Full Text] [Related]
37. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients.
van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC
Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887
[TBL] [Abstract][Full Text] [Related]
38. Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.
Bektaş G; Yeşil G; Özkan MU; Yıldız EP; Uzunhan TA; Çalışkan M
Clin Neurol Neurosurg; 2018 Aug; 171():190-193. PubMed ID: 29933199
[TBL] [Abstract][Full Text] [Related]
39. Defective translation initiation causes vanishing of cerebral white matter.
Scheper GC; Proud CG; van der Knaap MS
Trends Mol Med; 2006 Apr; 12(4):159-66. PubMed ID: 16545608
[TBL] [Abstract][Full Text] [Related]
40. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations.
Striano P; Mancardi MM; Biancheri R; Madia F; Gennaro E; Paravidino R; Beccaria F; Capovilla G; Dalla Bernardina B; Darra F; Elia M; Giordano L; Gobbi G; Granata T; Ragona F; Guerrini R; Marini C; Mei D; Longaretti F; Romeo A; Siri L; Specchio N; Vigevano F; Striano S; Tortora F; Rossi A; Minetti C; Dravet C; Gaggero R; Zara F
Epilepsia; 2007 Jun; 48(6):1092-6. PubMed ID: 17381446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
